• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

mBio . Recovery from Acute SARS-CoV-2 Infection and Development of Anamnestic Immune Responses in T Cell-Depleted Rhesus Macaques

tetano

Editor, Senior Moderator
mBio


. 2021 Jul 27;e0150321.
doi: 10.1128/mBio.01503-21. Online ahead of print.
Recovery from Acute SARS-CoV-2 Infection and Development of Anamnestic Immune Responses in T Cell-Depleted Rhesus Macaques


Kim J Hasenkrug[SUP] 1 [/SUP], Friederike Feldmann[SUP] 2 [/SUP], Lara Myers[SUP] 1 [/SUP], Mario L Santiago[SUP] 3 [/SUP], Kejun Guo[SUP] 3 [/SUP], Bradley S Barrett[SUP] 3 [/SUP], Kaylee L Mickens[SUP] 3 [/SUP], Aaron Carmody[SUP] 4 [/SUP], Atsushi Okumura[SUP] 5 [/SUP], Deepashri Rao[SUP] 1 [/SUP], Madison M Collins[SUP] 1 [/SUP], Ronald J Messer[SUP] 1 [/SUP], Jamie Lovaglio[SUP] 2 [/SUP], Carl Shaia[SUP] 2 [/SUP], Rebecca Rosenke[SUP] 2 [/SUP], Neeltje van Doremalen[SUP] 5 [/SUP], Chad Clancy[SUP] 2 [/SUP], Greg Saturday[SUP] 2 [/SUP], Patrick Hanley[SUP] 2 [/SUP], Brian J Smith[SUP] 2 [/SUP], Kimberly Meade-White[SUP] 5 [/SUP], W Lesley Shupert[SUP] 5 [/SUP], David W Hawman[SUP] 5 [/SUP], Heinz Feldmann[SUP] 5 [/SUP]



Affiliations

Abstract

Severe coronavirus disease 2019 (COVID-19) has been associated with T cell lymphopenia, but no causal effect of T cell deficiency on disease severity has been established. To investigate the specific role of T cells in recovery from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections, we studied rhesus macaques that were depleted of either CD4[SUP]+[/SUP], CD8[SUP]+[/SUP], or both T cell subsets prior to infection. Peak virus loads were similar in all groups, but the resolution of virus in the T cell-depleted animals was slightly delayed compared to that in controls. The T cell-depleted groups developed virus-neutralizing antibody responses and class switched to IgG. When reinfected 6 weeks later, the T cell-depleted animals showed anamnestic immune responses characterized by rapid induction of high-titer virus-neutralizing antibodies, faster control of virus loads, and reduced clinical signs. These results indicate that while T cells play a role in the recovery of rhesus macaques from acute SARS-CoV-2 infections, their depletion does not induce severe disease, and T cells do not account for the natural resistance of rhesus macaques to severe COVID-19. Neither primed CD4[SUP]+[/SUP] nor CD8[SUP]+[/SUP] T cells appeared critical for immunoglobulin class switching, the development of immunological memory, or protection from a second infection. IMPORTANCE Patients with severe COVID-19 often have decreased numbers of T cells, a cell type important in fighting most viral infections. However, it is not known whether the loss of T cells contributes to severe COVID-19 or is a consequence of it. We studied rhesus macaques, which develop only mild COVID-19, similar to most humans. Experimental depletion of T cells slightly prolonged their clearance of virus, but there was no increase in disease severity. Furthermore, they were able to develop protection from a second infection and produced antibodies capable of neutralizing the virus. They also developed immunological memory, which allows a much stronger and more rapid response upon a second infection. These results suggest that T cells are not critical for recovery from acute SARS-CoV-2 infections in this model and point toward B cell responses and antibodies as the essential mediators of protection from re-exposure.

Keywords: SARS-CoV-2; T cells; macaque; neutralizing antibodies.
 
Back
Top Bottom